相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
S. Budd Haeberlein et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2022)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
Guoqiao Wang et al.
STATISTICS IN MEDICINE (2018)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-beta Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
Stina Tucker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
Kristina Magnusson et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-A beta Antibodies
Dag Sehlin et al.
NEURODEGENERATIVE DISEASES (2011)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)